Alfred Sandrock Net Worth & Insider Trades

Alfred Sandrock - Head Research & Development, Biogen Inc

As of June 9, 2021

What is Alfred Sandrock's Net Worth?

The current estimated net worth of Biogen Inc's Head Research & Development, Alfred Sandrock, is estimated to be about $22.1M . Alfred Sandrock owns about 10,169 units of Biogen Inc common stock. In the last 8 years at Biogen Inc, Alfred Sandrock has sold an estimated value of $26.61M worth.

What is Alfred Sandrock's Past Insider Trading?

Alfred Sandrock's largest purchase order was 15,030 units , worth over $910.22K on October 23, 2013. Alfred Sandrock's largest sale order was 15,030 units , worth over $3.76M on October 23, 2013. In total, Alfred Sandrock has made about 46 transactions over 8 years of their time at Biogen Inc. Alfred Sandrock usually trades in February, with the busiest year in 2015 and 2014. The most recent transaction was a sale order of 7,672 units , worth over $3.38M on June 9, 2021.

Alfred Sandrock

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Alfred Sandrock's Salary in 2020?

As Head Research & Development of Biogen Inc, Alfred Sandrock has a total base salary of $890,310 . Alfred Sandrock received compensation valued at about $6,226,969 in 2020 after becoming Head Research & Development. The vast majority of their compensation came in the form of stock awards of $4,331,654 , other earnings, plans or compensations of $ 719,541 , change in pension value of $ 138,444 , and other compensation of $ 147,020 .

What is Alfred Sandrock's' Mailing Address?

  • Mailing address is 14 Cambridge Center Cambridge MA 02142 MA

Biogen Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
Michel Vounatsos 2020 $1,488,462 - $13,887,064 $2,565,000 $ 264,358 $ 454,945 $18,659,829
Michel Vounatsos 2019 $1,388,461 - $12,352,030 $3,884,000 $ 85,667 $ 449,700 $18,159,858
Michel Vounatsos 2018 $1,276,923 - $11,064,897 $3,337,880 $ 80,663 $ 408,283 $16,168,646
Michael R. McDonnell 2020 $294,231 $1,000,000 $5,012,308 $ 263,322 - $ 5,696 $6,575,557
Alfred W. Sandrock, Jr. 2020 $890,310 - $4,331,654 $ 719,541 $ 138,444 $ 147,020 $6,226,969
Alfred W. Sandrock, Jr. 2019 $798,723 - $3,360,682 $ 893,038 $ 78,506 $ 181,616 $5,312,565
Susan H. Alexander 2020 $809,695 - $3,583,281 $ 606,392 $ 311,416 $ 159,261 $5,470,045
Susan H. Alexander 2019 $772,373 - $3,302,619 $1,033,451 $ 164,782 $ 181,785 $5,455,010
Susan H. Alexander 2018 $746,254 - $4,359,590 $ 858,744 $ 188,056 $ 201,140 $6,353,784
Chirfi Guindo 2020 $562,819 - $3,961,285 $ 527,970 - $ 80,721 $5,132,795
Chirfi Guindo 2019 $526,539 - $3,379,426 $ 706,384 - $ 82,173 $4,694,522
Jeffrey D. Capello 2020 $671,132 - $3,901,503 - - $4,648,876 $9,221,511
Jeffrey D. Capello 2019 $783,173 - $4,051,891 $ 883,575 - $ 95,450 $5,814,089
Jeffrey D. Capello 2018 $750,000 - $2,889,224 $ 790,913 - $ 46,582 $4,476,719
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/875045/000119312521129003/d602779ddef14a.htm

What are Biogen Inc's Past Insider Trades?

Biogen Inc's most recent insider trade came on October 28, 2022 by Susan Alexander who sold 5,532 units worth $1.55M . In the last 19 years, insiders at Biogen Inc have sold an estimated value of $852.13M and bought an estimated value of $464.22M worth of shares. Insider trading is most common in February, with the busiest year in 2004. The most active traders at the company are James C Mullen, CEO & President,  Susan Alexander, EVP Chief Legal Off & Corp Sec,  and George A Scangos, Chief Executive Officer .

BIOGEN INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1